Liu Huining, Ohashi Takashi, Masuda Takao, Zhou Xin, Kubo Makoto, Kannagi Mari
Department of Immunotherapeutics, Medical Research Division, Tokyo Medical and Dental University, Tokyo, Japan.
Viral Immunol. 2003;16(3):381-93. doi: 10.1089/088282403322396172.
CD8+ cells of asymptomatic HIV-1 carriers (AC) contain HIV-1-specific cytotoxic T lymphocytes (CTLs) but suppress HIV-1 replication in a class I major histocompatibility complex (MHC-I)-unrestricted manner. In order to selectively investigate the HIV-1-suppressive function of CTLs apart from HIV-1-specific cytotoxicity, HIV-1-irrelevant allo-specific CTLs were established from an HIV-1-uninfected individual and their HIV-1-suppressive activity against autologous CD4+ peripheral blood mononuclear cells (PBMC) was examined. We found that these CTLs significantly suppressed both R5 and X4-HIV-1 replication in either acutely or persistently infected autologous PBMC. Although these CTLs partially killed HIV-1-infected PBMC through Fas ligand, CTLs still suppressed late steps of HIV-1 replication in the presence of neutralizing antibodies to Fas ligand. HIV-1 replication in PBMC that had been suppressed by CTLs was reversible following depletion of CTLs from culture, analogous to the previous observation for CD8+ cell-depleted PBMC of AC. Induction of HIV-1 replication by CTL-depletion was amplified by addition of newly prepared CD4+ cells or activation with staphylococcal enterotoxin B. Our results indicate that CTLs can suppress HIV-1 replication in PBMC in an antigen-nonspecific manner and preserve infected cells in a state capable of restarting HIV-1 replication and transmission.
无症状HIV-1携带者(AC)的CD8 +细胞含有HIV-1特异性细胞毒性T淋巴细胞(CTL),但以I类主要组织相容性复合体(MHC-I)非限制性方式抑制HIV-1复制。为了选择性研究CTL的HIV-1抑制功能,而不考虑HIV-1特异性细胞毒性,从一名未感染HIV-1的个体中建立了与HIV-1无关的同种异体特异性CTL,并检测了它们对自体CD4 +外周血单核细胞(PBMC)的HIV-1抑制活性。我们发现,这些CTL在急性或持续感染的自体PBMC中均能显著抑制R5和X4-HIV-1的复制。尽管这些CTL通过Fas配体部分杀伤HIV-1感染的PBMC,但在存在Fas配体中和抗体的情况下,CTL仍能抑制HIV-1复制的后期步骤。CTL抑制后的PBMC中的HIV-1复制在从培养物中去除CTL后是可逆的,这与之前对AC的CD8 +细胞耗竭的PBMC的观察结果类似。通过添加新制备的CD4 +细胞或用葡萄球菌肠毒素B激活,可增强CTL耗竭诱导的HIV-1复制。我们的结果表明,CTL可以以抗原非特异性方式抑制PBMC中的HIV-1复制,并使感染细胞保持在能够重新启动HIV-1复制和传播的状态。